Search research articles
Contact Us
Filters
Showing results (111-120 of 121) with videos related to
Page
of 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2021
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)
Robert L Ferris, Yael Flamand, Gregory S Weinstein, et al.
Journal for Immunotherapy of Cancer
|
July 17, 2019
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Ezra E W Cohen, R Bryan Bell, Carlo B Bifulco, et al.
JCI Insight
|
June 30, 2026
A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma
Jianguo Huang, Xingliang Liu, Warren Floyd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2025
Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus-Initiated Oropharynx Cancer
Barbara Burtness, Yael Flamand, Harry Quon, et al.
Head and Neck Pathology
|
July 24, 2023
HN-CLEAR: Head and Neck Consensus Language for Ease and Reproducibility, a Multidisciplinary Consensus Mechanism for Head and Neck Pathology
Ruta Gupta, Munita Bal, Justin A Bishop, et al.
Nature Communications
|
July 17, 2025
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy
Robert Saddawi-Konefka, Riyam Al Msari, Shiqi Tang, et al.
JCO Oncology Advances
|
April 2, 2026
Functional impact of transoral surgery and risk-based adjuvant therapy in human papillomavirus-associated oropharyngeal cancer: swallowing outcomes from ECOG-ACRIN E3311
Katherine A Hutcheson, Yael Flamand, Beatrice Manduchi, et al.
The New England Journal of Medicine
|
June 18, 2025
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
Ravindra Uppaluri, Robert I Haddad, Yungan Tao, et al.
Oral Oncology
|
July 18, 2020
A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311
Robert L Ferris, Yael Flamand, F Christopher Holsinger, et al.
The Journal of Trauma
|
August 5, 2011
Executive summary: Guidelines for the prevention of infections associated with combat-related injuries: 2011 update: endorsed by the Infectious Diseases Society of America and the Surgical Infection Society
Duane R Hospenthal, Clinton K Murray, Romney C Andersen, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 121) with videos related to
Sort By:
Page
of 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2021
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)
Robert L Ferris, Yael Flamand, Gregory S Weinstein, et al.
Journal for Immunotherapy of Cancer
|
July 17, 2019
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Ezra E W Cohen, R Bryan Bell, Carlo B Bifulco, et al.
JCI Insight
|
June 30, 2026
A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma
Jianguo Huang, Xingliang Liu, Warren Floyd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2025
Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus-Initiated Oropharynx Cancer
Barbara Burtness, Yael Flamand, Harry Quon, et al.
Head and Neck Pathology
|
July 24, 2023
HN-CLEAR: Head and Neck Consensus Language for Ease and Reproducibility, a Multidisciplinary Consensus Mechanism for Head and Neck Pathology
Ruta Gupta, Munita Bal, Justin A Bishop, et al.
Nature Communications
|
July 17, 2025
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy
Robert Saddawi-Konefka, Riyam Al Msari, Shiqi Tang, et al.
JCO Oncology Advances
|
April 2, 2026
Functional impact of transoral surgery and risk-based adjuvant therapy in human papillomavirus-associated oropharyngeal cancer: swallowing outcomes from ECOG-ACRIN E3311
Katherine A Hutcheson, Yael Flamand, Beatrice Manduchi, et al.
The New England Journal of Medicine
|
June 18, 2025
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
Ravindra Uppaluri, Robert I Haddad, Yungan Tao, et al.
Oral Oncology
|
July 18, 2020
A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311
Robert L Ferris, Yael Flamand, F Christopher Holsinger, et al.
The Journal of Trauma
|
August 5, 2011
Executive summary: Guidelines for the prevention of infections associated with combat-related injuries: 2011 update: endorsed by the Infectious Diseases Society of America and the Surgical Infection Society
Duane R Hospenthal, Clinton K Murray, Romney C Andersen, et al.
Page
of 13